Works matching DE "MELINTA Therapeutics Inc."

Melinta Therapeutics Announces US FDA Approval of Delafloxacin for Acute Bacterial Skin and Skin Structure Infections.

Published in:

Clinical Infectious Diseases, 2017, v. 65, n. 5, p. i, doi. 10.1093/cid/cix614

Publication type:

Article